Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
5.19
-0.02 (-0.38%)
Aug 26, 2026, 11:04 AM EDT - Market open

Oramed Pharmaceuticals Revenue

In the year 2025, Oramed Pharmaceuticals had annual revenue of $2.00M.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
215.89M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.00M--
Dec 31, 2024---
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M1.80M199.00%
Dec 31, 2021904.00K-1.80M-66.56%
Aug 31, 20212.70M-7.00K-0.26%
Aug 31, 20202.71M7.00K0.26%
Aug 31, 20192.70M254.00K10.37%
Aug 31, 20182.45M-7.00K-0.29%
Aug 31, 20172.46M1.82M283.15%
Aug 31, 2016641.00K--
Aug 31, 2015---
Aug 31, 2014---
Aug 31, 2013---
Aug 31, 2012---
Aug 31, 2011---
Aug 31, 2010---
Aug 31, 2009---
Aug 31, 2008---
Aug 31, 2007---
Aug 31, 2006---
Aug 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Protalix BioTherapeutics80.62M
Voyager Therapeutics34.46M
Tonix Pharmaceuticals Holding29.10M
Alpha Cognition15.26M
Keros Therapeutics15.01M
Innate Pharma10.57M
Armata Pharmaceuticals5.54M
Korro Bio2.38M
Revenue Rankings

ORMP News

More News